Nexstim logo

Changes in Nexstim Plc’s management Team, 9 March 2017

09 March 2017

Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients with the use of non-invasive brain stimulation, announces that Petriina Puolakka will be stepping down from her role as Vice President, Legal Affairs and the member of the Management Team as of 7 April 2017 and will pursue opportunities outside the company.



Martin Jamieson, Chairman and CEO


For further information please visit or contact:


Nexstim                                                                                                                                    +447715163942

Martin Jamieson, Chairman and CEO                                         


UB Securities Oy (Certified Adviser)                                                                         +358 (0)9 2538 0246


Citigate Dewe Rogerson                                                                                               +44 (0)207 2821066

Katja Stout                                                                                              


About Nexstim Plc

Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the Company has developed a system called Navigated Brain Therapy (NBT®) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit



Back to Press Releases